Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
OneroRx
AddedFeb 15, 2024
UpdatedJun 18, 2026
OneroRx

OneroRx

Series B

OneroRx: Providing telepharmacy services to urban and rural communities since 2019.

HQ
West Des Moines, IA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

OneroRx, founded in 2019 and headquartered in West Des Moines, Iowa, is a telepharmacy service provider dedicated to delivering quality and affordable pharmacy care to underserved urban and rural communities. The company's core mission is to bridge the gap in pharmacy access for millions of Americans who live in "pharmacy deserts," areas where local or chain pharmacies have closed or are not available. OneroRx leverages technology to ensure that everyone, regardless of location, has access to essential medications and pharmaceutical services.

The company has garnered attention for its innovative approach to addressing healthcare disparities through telepharmacy. Notable affiliated individuals and investors include healthcare professionals and venture capitalists committed to improving public health. Key achievements include expanding their service reach to numerous underserved areas and positively impacting the health outcomes of countless individuals. OneroRx's overall impact lies in its ability to provide critical pharmacy services where they are needed most, thereby enhancing the quality of life for many Americans.

OneroRx - Similar Companies

RxLive logo

RxLive

rxlive.com

PipelineRx logo

PipelineRx

pipelinerx.com

Health Haven Rx logo

Health Haven Rx

healthhavenrx.com

mymedscom logo

mymedscom

mymedscom.com

GeniusRx logo

GeniusRx

geniusrx.com

NimbleRx logo

NimbleRx

nimblerx.com

Medication Review logo

Medication Review

Aspen RxHealth logo

Aspen RxHealth

aspenrxhealth.com

Honeybee Health logo

Honeybee Health

honeybeehealth.com

OptioRx logo

OptioRx

optiorx.com

AlixaRx logo

AlixaRx

alixarx.com

DiRx logo

DiRx

dirxhealth.com

Onco360 Oncology Pharmacy logo

Onco360 Oncology Pharmacy

onco360.com

Rx Delivered Now logo

Rx Delivered Now

rxdeliverednow.com

Pills2Me logo

Pills2Me

pills2me.com

OneroRx - Quick Facts

Who are OneroRx's competitors?

Companies similar to OneroRx include RxLive, PipelineRx, Health Haven Rx and mymedscom.

When was OneroRx founded?

OneroRx was founded in 2019.

Where is OneroRx's headquarters located?

OneroRx's headquarters is located in West Des Moines, IA, US.

How much has OneroRx raised to-date?

As of Jan 25, 2024, OneroRx has raised a total of $20M (USD).

How many employees does OneroRx have?

OneroRx has 13 employees as of Feb 5, 2024.

OneroRx - Classification

Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Telepharmacy
Tags
  • Healthtech
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 5900Miscellaneous Retail
  • 5910Drug Stores And Proprietary Stores
  • 5912Drug Stores and Proprietary Stores
ISIC
  • 4772Retail sale of pharmaceutical and medical goods, cosmetic and toilet articles in specialized stores
Show 6 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified